Drug-induced hyperphagia: What can we learn from psychiatric medications?

被引:16
作者
Jensen, Gordon L. [1 ]
机构
[1] Vanderbilt Ctr Human Nutr, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
psychiatric; medications; hyperphagia; apetite; weight gain; obesity;
D O I
10.1177/0148607108321708
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This brief review examines hyperphagia and associated weight gain as undesirable side effects of psychiatric medications exploring the scope oil the problem, proposed mechanisms, and potential interventions. Mechanisms of action appear to include durg-mediated effects on hypothalamic appetite pathways that have been implicated in other etiologies of obesity There is great individual variation in response to these medications as well as variation in file degree of weight gain Within drug classes. Gene polymorphisms may be a key factor in determining individual variations in response. Better understanding of the underlying mechanisms can guide useful interventions. Medication selection and dosing appear to be important strategies to minimize adverse weight gain.
引用
收藏
页码:578 / 581
页数:4
相关论文
共 56 条
[21]   Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine [J].
Gothelf, D ;
Falk, B ;
Singer, P ;
Kairi, M ;
Phillip, M ;
Zigel, L ;
Poraz, I ;
Frishman, S ;
Constantini, N ;
Zalsman, G ;
Weizman, A ;
Apter, A .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :1055-1057
[22]   Antipsychotic-induced weight gain [J].
Goudie, AJ ;
Cooper, GD ;
Halford, JCG .
DIABETES OBESITY & METABOLISM, 2005, 7 (05) :478-487
[23]   Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors [J].
Harvey, BH ;
Bouwer, CD .
CLINICAL NEUROPHARMACOLOGY, 2000, 23 (02) :90-97
[24]   Early prediction of changes in weight during six weeks of treatment with antidepressants [J].
Himmerich, H ;
Schuld, A ;
Haack, M ;
Kaufmann, C ;
Pollmächer, T .
JOURNAL OF PSYCHIATRIC RESEARCH, 2004, 38 (05) :485-489
[25]   Genetic variants of the serotonin system and weight change during clozapine treatment [J].
Hong, CJ ;
Lin, CH ;
Yu, YWY ;
Yang, KH ;
Tsai, SJ .
PHARMACOGENETICS, 2001, 11 (03) :265-268
[26]   Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms [J].
Jain, AK ;
Kaplan, RA ;
Gadde, KM ;
Wadden, TA ;
Allison, DB ;
Brewer, ER ;
Leadbetter, RA ;
Richard, N ;
Haight, B ;
Jamerson, BD ;
Buaron, KS ;
Metz, A .
OBESITY RESEARCH, 2002, 10 (10) :1049-1056
[27]   Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial [J].
Keck, PE ;
Versiani, M ;
Potkin, S ;
West, SA ;
Giller, E ;
Ice, K .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04) :741-748
[28]   Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus [J].
Kirk, Shona L. ;
Cahir, Marie ;
Reynolds, Gavin P. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (04) :577-579
[29]   Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series [J].
Kirov, George ;
Tredget, John .
BMC PSYCHIATRY, 2005, 5 (1)
[30]   WEIGHT-GAIN, INCREASED APPETITE, AND EXCESSIVE FOOD-INTAKE INDUCED BY CARBAMAZEPINE [J].
LAMPL, Y ;
ESHEL, Y ;
RAPAPORT, A ;
SAROVAPINHAS, I .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :251-255